(Q36670845)

15 August 2017

1 reference

title

Agomelatine: a preliminary review of a new antidepressant (English)

1 reference

15 August 2017

Christian Guilleminault

series ordinal

2

object named as

Christian Guilleminault

0 references

author name string

Michael Zupancic

series ordinal

1

1 reference

15 August 2017

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

20

1 reference

15 August 2017

981-992

1 reference

15 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200620120-00003

15 August 2017

0 references

cites work

Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus

1 reference

12 December 2020

A neurotrophic model for stress-related mood disorders

1 reference

12 December 2020

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

1 reference

12 December 2020

Remodeling of neuronal networks by stress

1 reference

12 December 2020

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).

1 reference

12 December 2020

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

1 reference

12 December 2020

Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis

1 reference

12 December 2020

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

1 reference

12 December 2020

Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent

1 reference

12 December 2020

Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.

1 reference

12 December 2020

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

1 reference

12 December 2020

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

1 reference

12 December 2020

Antidepressant action of agomelatine (S 20098) in a transgenic mouse model

1 reference

12 December 2020

Neuroimaging studies of mood disorder effects on the brain

1 reference

12 December 2020

Melatonin in mood disorders

1 reference

12 December 2020

Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms

1 reference

12 December 2020

Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis

1 reference

12 December 2020

Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal.

1 reference

12 December 2020

Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders

1 reference

12 December 2020

Effect of agomelatine in the chronic mild stress model of depression in the rat.

1 reference

12 December 2020

Hippocampal volume reduction in major depression.

1 reference

12 December 2020

Nocturnal temperature in affective disorder.

1 reference

12 December 2020

Novel naphthalenic ligands with high affinity for the melatonin receptor

1 reference

12 December 2020

Daytime sleepiness and insomnia as correlates of depression.

1 reference

12 December 2020

Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study

1 reference

12 December 2020

Neurogenesis in the adult human hippocampus

1 reference

12 December 2020

Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety

1 reference

12 December 2020

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

1 reference

12 December 2020

Chronic exposure to melatonin receptor agonists does not alter their effects on suprachiasmatic nucleus neurons.

1 reference

12 December 2020

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

1 reference

12 December 2020

10.2165/00023210-200620120-00003

Identifiers

DOI

1 reference

PubMed ID

17140278

Dimensions Publication ID

15 August 2017

1004418283

0 references

Fatcat ID

release_zbcjeop35rez3oqsoevoa7bf74

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zbcjeop35rez3oqsoevoa7bf74

24 November 2022

mapped directly with Wikidata item

PubMed ID

17140278

1 reference

PubMed ID

17140278